Food News and Research

RSS

Monoclonal antibody treatment of COVID-19 reduces viral shedding

Researchers aim to understand the potential benefits of mAbs in preventing and treating SARS-CoV-2 infection.

5 Jan 2022

Transplant recipients benefit from a COVID-19 vaccine booster

A new preprint research paper posted to the medRxiv* server describes the reduction in humoral immunity in SOTR following vaccination, as well as the improvement with an additional dose of the vaccine.

4 Jan 2022

Prime Minister updates the public on UK government’s ongoing actions to tackle COVID-19

The Prime Minister today updated the public on the government's ongoing actions to tackle COVID-19 and prevent the NHS from being overwhelmed, including implementing Plan B measures, standing up local Nightingales to create extra capacity, buying more antivirals per person than anywhere else in Europe, significantly increasing testing capacity and rolling out the vital booster program.

4 Jan 2022

Research demonstrates the safety, feasibility of psilocybin administered at doses of 10mg or 25mg

New research from the Institute of Psychiatry, Psychology, & Neuroscience (IoPPN) at King's College London, in partnership with COMPASS Pathways, has established that psilocybin can be safely administered at doses of either 10mg or 25mg to up to six participants simultaneously.

4 Jan 2022

Israeli study confirms drop in BNT162b2 efficacy after six months

Researchers determine whether BNT162b2 vaccination has become less efficient in preventing infection over time.

4 Jan 2022

Sustainable diet can lower the risk of bleeding or blood clots in the brain

The risk of bleeding or blood clots in the brain is lower if your diet is sustainable. This is shown by a new research result from Aarhus University. The results have just been published in the scientific journal Stroke.

4 Jan 2022

In vitro effect of several antiviral drugs against various SARS-CoV-2 variants of concern

An independent study confirms that current and prospective antiviral treatments are effective in inhibiting severe infection from SARS-CoV-2.

4 Jan 2022

Siemens Healthineers Announces FDA Emergency Use Authorization for CLINITEST® Rapid COVID-19 Antigen Self-Test

The CLINITEST Rapid COVID-19 Antigen Self-Test has received FDA EUA for unsupervised self-testing for the SARS-CoV-2 virus by individuals age 14 and older (or adult-collected samples from individuals ages 2-13).

From Siemens Healthineers 4 Jan 2022

Eating human food profoundly impacts the microbiome of black bears

A recent study suggests that eating human food has a pronounced effect on the microbiome of black bears.

3 Jan 2022

Recommended choline intake during pregnancy improves child's sustained attention

Seven-year-old children performed better on a challenging task requiring sustained attention if their mothers consumed twice the recommended amount of choline during their pregnancy, a new Cornell study has found.

3 Jan 2022

COVID-19 tests with the new assay may be just as reliable as laboratory-based molecular tests

Researchers at the University of Illinois Chicago have designed a high-quality assay that can be used in at-home tests for rapid COVID-19 screening.

3 Jan 2022

New treatment method leads to fewer episodes of overeating in patients with morbid obesity

Patients with morbid obesity experienced improvement in their quality of life and distinctly fewer episodes of overeating after ten weeks with a new treatment method developed at NTNU.

3 Jan 2022

New systematic review finds low-quality evidence on the effectiveness of hangover remedies

A new systematic review has found only very low-quality evidence that substances claiming to treat or prevent alcohol-induced hangover work.

3 Jan 2022

Study shows structural and functional aspects of antibody neutralization of SARS-CoV-2 Omicron variant

Researchers investigated the potency of trimeric human nephrocystin SH3, TriSb92, a domain-derived antibody, against a conserved region in the receptor-binding domain (RBD) of the spike protein in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern.

31 Dec 2021

COVID-19 vaccine appears safe in children aged 5–11 Years

A new report notes menial or nil severe adverse events from vaccination against COVID-19 in children and therefore recommends COVID-19 vaccination among children aged 5-11 years old.

31 Dec 2021

Researchers warn about the dangers of vitamin B12 deficiency in people following plant-based diets

In the run up to Veganuary leading researchers are warning of the dangers of a quiet epidemic of vitamin B12deficiencyin people who follow increasingly popular plant-based diets.

30 Dec 2021

A reliable assessment of COVID-19 vaccine protection duration

Researchers from the University of North Carolina, University of Washington, and the US Food and Drug Administration propose fitting a Cox model with two time indexes, the event times measured from the start of the study in calendar time and the log hazard for the vaccine effect.

30 Dec 2021

The use of monoclonal antibodies against infectious pathogens

Joshua Tan of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health wrote a review article in the journal DNA and Cell Biology about the role of monoclonal antibodies and briefly described a study on bispecific antibodies that neutralize SARS-CoV-2.

30 Dec 2021

Healthy dietary habits help reduce risk of gestational diabetes mellitus in pregnant women

Obesity is a significant risk factor for developing gestational diabetes mellitus, and an increasing number of pregnant women are overweight or obese. Dietary habits have an impact on both obesity and the onset of gestational diabetes mellitus.

30 Dec 2021

3-dose vaccines deemed ultrapotent against diverse and highly transmissible SARS-CoV-2 Omicron and other variants

A new study found that the presence of a subset of antibodies with broad neutralizing activities against all circulating variants of concern in the three-dose vaccines' memory B-derived antibody repertoire suggests that the Omicron/future variants infection may elicit selective and rapid recall of humoral responses, conferring secondary protection directed by memory etched in the immune system.

29 Dec 2021

Food News and Research

Monoclonal antibody treatment of COVID-19 reduces viral shedding

Transplant recipients benefit from a COVID-19 vaccine booster

Prime Minister updates the public on UK government’s ongoing actions to tackle COVID-19

Research demonstrates the safety, feasibility of psilocybin administered at doses of 10mg or 25mg

Israeli study confirms drop in BNT162b2 efficacy after six months

Sustainable diet can lower the risk of bleeding or blood clots in the brain

In vitro effect of several antiviral drugs against various SARS-CoV-2 variants of concern

Siemens Healthineers Announces FDA Emergency Use Authorization for CLINITEST® Rapid COVID-19 Antigen Self-Test

Eating human food profoundly impacts the microbiome of black bears

Recommended choline intake during pregnancy improves child's sustained attention

COVID-19 tests with the new assay may be just as reliable as laboratory-based molecular tests

New treatment method leads to fewer episodes of overeating in patients with morbid obesity

New systematic review finds low-quality evidence on the effectiveness of hangover remedies

Study shows structural and functional aspects of antibody neutralization of SARS-CoV-2 Omicron variant

COVID-19 vaccine appears safe in children aged 5–11 Years

Researchers warn about the dangers of vitamin B12 deficiency in people following plant-based diets

A reliable assessment of COVID-19 vaccine protection duration

The use of monoclonal antibodies against infectious pathogens

Healthy dietary habits help reduce risk of gestational diabetes mellitus in pregnant women

3-dose vaccines deemed ultrapotent against diverse and highly transmissible SARS-CoV-2 Omicron and other variants

Understanding cultivated meat and its global potential eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News